1. Home
  2. RNXT vs PRTS Comparison

RNXT vs PRTS Comparison

Compare RNXT & PRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • PRTS
  • Stock Information
  • Founded
  • RNXT 2012
  • PRTS 1995
  • Country
  • RNXT United States
  • PRTS United States
  • Employees
  • RNXT N/A
  • PRTS N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • PRTS Auto & Home Supply Stores
  • Sector
  • RNXT Health Care
  • PRTS Consumer Discretionary
  • Exchange
  • RNXT Nasdaq
  • PRTS Nasdaq
  • Market Cap
  • RNXT 44.6M
  • PRTS 44.9M
  • IPO Year
  • RNXT 2021
  • PRTS 2007
  • Fundamental
  • Price
  • RNXT $1.32
  • PRTS $0.78
  • Analyst Decision
  • RNXT Strong Buy
  • PRTS Buy
  • Analyst Count
  • RNXT 2
  • PRTS 2
  • Target Price
  • RNXT $7.25
  • PRTS $1.40
  • AVG Volume (30 Days)
  • RNXT 150.2K
  • PRTS 361.5K
  • Earning Date
  • RNXT 08-14-2025
  • PRTS 07-29-2025
  • Dividend Yield
  • RNXT N/A
  • PRTS N/A
  • EPS Growth
  • RNXT N/A
  • PRTS N/A
  • EPS
  • RNXT N/A
  • PRTS N/A
  • Revenue
  • RNXT $240,000.00
  • PRTS $569,935,000.00
  • Revenue This Year
  • RNXT $3,104.65
  • PRTS $1.73
  • Revenue Next Year
  • RNXT $301.89
  • PRTS $5.48
  • P/E Ratio
  • RNXT N/A
  • PRTS N/A
  • Revenue Growth
  • RNXT N/A
  • PRTS N/A
  • 52 Week Low
  • RNXT $0.75
  • PRTS $0.68
  • 52 Week High
  • RNXT $1.69
  • PRTS $1.45
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 50.28
  • PRTS 48.50
  • Support Level
  • RNXT $1.28
  • PRTS $0.70
  • Resistance Level
  • RNXT $1.40
  • PRTS $0.79
  • Average True Range (ATR)
  • RNXT 0.07
  • PRTS 0.03
  • MACD
  • RNXT -0.01
  • PRTS 0.01
  • Stochastic Oscillator
  • RNXT 40.74
  • PRTS 83.50

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About PRTS CarParts.com Inc.

CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.

Share on Social Networks: